根据协议,4D将向$Fortress Biotech(FBIO)$ 旗下子公司Aevitas支付总计1.4亿美元,用于潜在的后期开发、监管和销售里程碑,以及销售特许权使用费。
两家公司表示,这笔款...查看全文
美股滚雪球2021-11-16 16:05
别人是卖药赚钱,$Fortress Biotech(FBIO)$ 是卖公司:阿斯利康收购了它的子公司Caelum Biosciences,收到预付款5690万美元,又一家子公司Journey Medical Corporation准备IPO。$恒瑞医药(SH600276)$ $长春高新(SZ000661)$查看全文
美股滚雪球2021-09-30 10:25
$Fortress Biotech(FBIO)$ 因阿斯利康名下的ALXN并购了自己的子公司Caelum而大涨,FBIO有望获得6400万美元,这是文中介绍的积极抓住子公司资产的合作、出售等商业化机会。 $恒瑞医药(SH600276)$ $沃森生物(SZ300142)$查看全文
美股滚雪球2021-06-07 09:59
本文摘要:
1、Hub-and-Spoke模式为何在创新药行业兴起?
2、Hub-and-Spoke模式的优点和缺点有哪些?
3、Hub-and-Spoke模式的案例分析
$Centessa(CNTA)$ $BridgeBio Pharma(BBIO)$ $Fortress Biotech(FBIO)$查看全文
美股律师郝俊波2020-12-01 17:43
$Fortress Biotech(FBIO)$ 【 Fortress Biotech Inc最新证券诉讼 】
Fortress Biotech Inc (FBIO)因证券欺诈案已经于近日被投资者诉至法院。在目前的诉讼中投资者指控该公司在2019年12月11日至2020年10月9日期间就公司的业务运营状况和合规政策进行虚假陈述,为向投资者披露以下重大不利事实...查看全文
$Fortress Biotech, Inc.(FBIO)$ 8-K - Current report Filed: 2017-11-07 AccNo: 0001144204-17-056956 Size: 391 KBItem 1.01: Entry into a Material Definitive AgreementItem 3.03: Material Modifications to Rights of Security HoldersItem 5.03: Amendments to Articles of Incorporation...
$Fortress Biotech, Inc.(FBIO)$ 8-A12B - Registration of securities [Section 12(b)] Filed: 2017-11-07 AccNo: 0001144204-17-056958 Size: 18 KB 网页链接
$Fortress Biotech, Inc.(FBIO)$ 8-K - Current report Filed: 2017-11-07 AccNo: 0001144204-17-056956 Size: 391 KBItem 1.01: Entry into a Material Definitive AgreementItem 3.03: Material Modifications to Rights of Security HoldersItem 5.03: Amendments to Articles of Incorporation...
$Fortress Biotech, Inc.(FBIO)$ FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses Filed: 2017-11-07 AccNo: 0001144204-17-056677 Size: 18 KB 网页链接
$Fortress Biotech, Inc.(FBIO)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2017-11-01 AccNo: 0001571049-17-008384 Size: 524 KB 网页链接
$Fortress Biotech, Inc.(FBIO)$ SC 13D - General statement of acquisition of beneficial ownership Filed: 2017-10-19 AccNo: 0001144204-17-053129 Size: 49 KB 网页链接
$Fortress Biotech, Inc.(FBIO)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-08-09 AccNo: 0001144204-17-041727 Size: 12 MB 网页链接
$Fortress Biotech, Inc.(FBIO)$ 8-K - Current report Filed: 2017-08-09 AccNo: 0001144204-17-041699 Size: 3 MBItem 2.02: Results of Operations and Financial ConditionItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Fortress Biotech, Inc.(FBIO)$ 8-K - Current report Filed: 2017-06-30 AccNo: 0001144204-17-035251 Size: 20 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$Fortress Biotech, Inc.(FBIO)$ 8-K - Current report Filed: 2017-06-12 AccNo: 0001144204-17-032124 Size: 208 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 5.07:...